当前位置:科学网首页 > 小柯机器人 >详情
滤泡外B细胞反应与中和抗体和COVID-19发病率相关
作者:小柯机器人 发布时间:2020/10/11 21:37:15

美国埃默里大学Ignacio Sanz、F. Eun-Hyung Lee等研究人员合作发现,滤泡外B细胞反应与中和抗体和COVID-19发病率相关。相关论文于2020年10月7日在线发表于国际学术期刊《自然—免疫学》。

研究人员通过高维流式细胞术对B细胞反应进行了详细的表征,以揭示效应子和未成熟群体中的大量异质性。值得注意的是,重症患者表现出滤泡外B细胞活化的特征,并具有先前在自身免疫环境中描述的共享B细胞库特征。卵泡外激活和分泌抗体的大细胞扩增与高浓度的SARS-CoV-2特异性中和抗体的早期产生密切相关。然而,这些患者患有严重的疾病,其炎症生物标志物升高,多器官衰竭和死亡。
 
总体而言,这些发现强烈暗示了COVID-19患者亚型中免疫激活的致病作用。这项研究提供了进一步的证据,表明针对性的免疫调节疗法可能对特定的患者亚群有益,并且可以通过仔细的免疫分析来了解。
 
据介绍,广泛的临床表现已成为COVID-19大流行的标志,尽管各种疾病结局的免疫学基础尚待确定。
 
附:英文原文

Title: Extrafollicular B cell responses correlate with neutralizing antibodies and morbidity in COVID-19

Author: Matthew C. Woodruff, Richard P. Ramonell, Doan C. Nguyen, Kevin S. Cashman, Ankur Singh Saini, Natalie S. Haddad, Ariel M. Ley, Shuya Kyu, J. Christina Howell, Tugba Ozturk, Saeyun Lee, Naveenchandra Suryadevara, James Brett Case, Regina Bugrovsky, Weirong Chen, Jacob Estrada, Andrea Morrison-Porter, Andrew Derrico, Fabliha A. Anam, Monika Sharma, Henry M. Wu, Sang N. Le, Scott A. Jenks, Christopher M. Tipton, Bashar Staitieh, John L. Daiss, Eliver Ghosn, Michael S. Diamond, Robert H. Carnahan, James E. Crowe, William T. Hu, F. Eun-Hyung Lee, Ignacio Sanz

Issue&Volume: 2020-10-07

Abstract: A wide spectrum of clinical manifestations has become a hallmark of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) COVID-19 pandemic, although the immunological underpinnings of diverse disease outcomes remain to be defined. We performed detailed characterization of B cell responses through high-dimensional flow cytometry to reveal substantial heterogeneity in both effector and immature populations. More notably, critically ill patients displayed hallmarks of extrafollicular B cell activation and shared B cell repertoire features previously described in autoimmune settings. Extrafollicular activation correlated strongly with large antibody-secreting cell expansion and early production of high concentrations of SARS-CoV-2-specific neutralizing antibodies. Yet, these patients had severe disease with elevated inflammatory biomarkers, multiorgan failure and death. Overall, these findings strongly suggest a pathogenic role for immune activation in subsets of patients with COVID-19. Our study provides further evidence that targeted immunomodulatory therapy may be beneficial in specific patient subpopulations and can be informed by careful immune profiling. 

DOI: 10.1038/s41590-020-00814-z

Source: https://www.nature.com/articles/s41590-020-00814-z

期刊信息

Nature Immunology:《自然—免疫学》,创刊于2000年。隶属于施普林格·自然出版集团,最新IF:23.53
官方网址:https://www.nature.com/ni/
投稿链接:https://mts-ni.nature.com/cgi-bin/main.plex